News

Brain Trust Bio Enters Investigational New Drug Enabled Studies for Continuous Intrathecal Drug Delivery Method

ATLANTA, August 1, 2022 — Brain Trust Bio , a next-generation biotechnology company, dedicated to improving the performance of the best medicines for central nervous system (CNS) conditions, today announced it has entered into Investigational New Drug (IND)-enabled studies for its continuous intrathecal (IT) drug delivery method. “The acceptance of our application to enter into […]